The use of GLP-1 medications -- particularly semaglutide, the active ingredient in Ozempic and Wegovy -- was associated with fewer psychiatric hospital visits and reduced sickness absence
Compared to traditional weight loss strategies, such as diet and exercise alone, GLP-1-based treatments offer a significant advantage, particularly for individuals who struggle with managing hunger
All products listed above are tested by a third party
Choose an injection site on your abdomen, thigh, or upper arm, rotating locations each week to prevent tissue damage and ensure consistent absorption
Neither injectable Wegovy nor Ozempic have these restrictions
Ozempic should be stopped at least 2 months before planned pregnancy and is not suitable during breastfeeding